|4Mar 10, 5:16 PM ET

IMPLANT SCIENCES CORP 4

4 · IMPLANT SCIENCES CORP · Filed Mar 10, 2014

Insider Transaction Report

Form 4
Period: 2014-03-06
Jones Darryl
Vice President, Sales and Mktg
Transactions
  • Award

    Stock Option(Right to Buy)

    2014-03-06+50,00050,000 total
    Exercise: $0.79Exp: 2024-03-05Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]These options will vest and become exercisable in full upon the later of (i) the addition of the Issuer's QS-B220 product to the Transportation Security Administration (TSA) Qualified Product List for passenger checkpoint screening and (ii) the Issuer's receipt of an initial order for such products under an indefinite delivery/indefinite quantity contract with the TSA.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT